Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience.
Biomedicines
Amati, Francesco F; Gramegna, Andrea A; Contarini, Martina M; Stainer, Anna A; Curcio, Cristina C; Aliberti, Stefano S; Corsico, Angelo Guido AG; Blasi, Francesco F
Genomic stability at the coding regions of the multidrug transporter gene ABCB1: insights into the development of alternative drug resistance mechanisms in human leukemia cells.
Cancer Drug Resistance (Alhambra, Calif.)
Chen, Kevin G KG; Duran, George E GE; Mogul, Mark J MJ; Wang, Yan C YC; Ross, Kevin L KL; Jaffrézou, Jean-Pierre JP; Huff, Lyn M LM; Johnson, Kory R KR; Fojo, Tito T; Lacayo, Norman J NJ; Sikic, Branimir I BI
Recent Strategic Advances in CFTR Drug Discovery: An Overview.
International Journal Of Molecular Sciences
Rusnati, Marco M; D'Ursi, Pasqualina P; Pedemonte, Nicoletta N; Urbinati, Chiara C; Ford, Robert C RC; Cichero, Elena E; Uggeri, Matteo M; Orro, Alessandro A; Fossa, Paola P
∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.
Nature
Pankow, Sandra S; Bamberger, Casimir C; Calzolari, Diego D; Martínez-Bartolomé, Salvador S; Lavallée-Adam, Mathieu M; Balch, William E WE; Yates, John R JR
Correction of both NBD1 energetics and domain interface is required to restore ΔF508 CFTR folding and function.
Cell
Rabeh, Wael M WM; Bossard, Florian F; Xu, Haijin H; Okiyoneda, Tsukasa T; Bagdany, Miklos M; Mulvihill, Cory M CM; Du, Kai K; di Bernardo, Salvatore S; Liu, Yuhong Y; Konermann, Lars L; Roldan, Ariel A; Lukacs, Gergely L GL
The cystic fibrosis-causing mutation deltaF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis.
The Journal Of Biological Chemistry
Thibodeau, Patrick H PH; Richardson, John M JM; Wang, Wei W; Millen, Linda L; Watson, Jarod J; Mendoza, Juan L JL; Du, Kai K; Fischman, Sharon S; Senderowitz, Hanoch H; Lukacs, Gergely L GL; Kirk, Kevin K; Thomas, Philip J PJ